UK Short-Circuits OTC Device Pain Relief Claims For Diabetics, Arthritics
Ad claims for Actegy's Revitive Circulation Booster device did not rely on clinical evidence that tested the actual product in the way consumers were advised to use it, UK advertising regulator says. Actegy maintained benefits from the device's TENS technology are similar to the effects of NMES technology used in studies it offered as evidence.
You may also be interested in...
GSK Consumer purchases ex-US rights to pain relief device Quell from NeuroMetrix in a deal that includes co-development of transcutaneous electrical nerve stimulation products.
Patterson Medical adds Performance Health; EarlySense targets consumer expansion; faster capsule filler available; and more news in brief.
Vous Vitamins partners with employers on its Employer Vitamin Education & Access Perks Program to offer their employees customized vitamins at a discount. The firm says the program will help consumers similar to allowing spending on supplements with pre-tax savings accounts.